Affiliation: University of East Anglia
- The use of wide-scale mental agility testing to identify people at risk of dementia: crucial or harmful?C Fox
C Fox Department of Clinical Psychology Norwich Medical School Faculty of Medicine and Health Sciences University of East Anglia, UK tel 44 0 603 593 177 e mail C Alessi Chairman National Association of Primary Care Lettsom House 11 Chandos Street, London, W1G 9DP e mail
J R Coll Physicians Edinb 44:30-5. 2014..While there is debate over the approach, we can agree that the economic and social impacts of this condition need to be addressed sooner rather than later. ..
- A pharmacy led program to review anti-psychotic prescribing for people with dementiaAnne Child
Avante Care and Support, De Gesley House, 1 Jubilee Way, Faversham, Kent ME13 8GD, UK
BMC Psychiatry 12:155. 2012..Anti-psychotics, prescribed to people with dementia, are associated with approximately 1,800 excess annual deaths in the UK. A key public health objective is to limit such prescribing of anti-psychotics...
- Designing a complex intervention for dementia case management in primary careAmy Waugh
Mental Health Sciences Unit, University College London, Charles Bell House, 67 73 Riding House Street, London W1W 7EJ, UK
BMC Fam Pract 14:101. 2013..Medical Research Council guidance on the development of complex interventions was implemented in the adaptation process, to capture the skill sets, person characteristics and learning needs of primary care based case managers...
- Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trialChris Fox
Department of Psychiatry, University of East Anglia, Norwich, United Kingdom
PLoS ONE 7:e35185. 2012..We tested the primary hypothesis, memantine is superior to placebo for clinically significant agitation, in patients with moderate-to-severe AD...
- Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing studyChris Fox
Department of Psychiatry, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
J Am Geriatr Soc 59:1477-83. 2011..To determine whether the use of medications with possible and definite anticholinergic activity increases the risk of cognitive impairment and mortality in older people and whether risk is cumulative...
- The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD studyChris Fox
Dementia Research Innovation Group, Norwich School of Medicine, Norwich Research Park, University of East Anglia, UK
Age Ageing 40:730-5. 2011..to examine the effect of medications with anticholinergic effects on cognitive impairment and deterioration in Alzheimer's dementia (AD)...
- Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee
Institute of Psychiatry, Health Services and Population Research Department, King s College London, London, UK
Lancet 378:403-11. 2011..We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo...
- Assessment of people with cognitive impairment and hip fracture: a systematic review and meta-analysisToby Smith
Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK
Arch Gerontol Geriatr 57:117-26. 2013..Based on the current available data, delirium may be best assessed using the NEECHAM Confusion Scale or DRS-R-98. Pain is most accurately evaluated using the FACS...
- Understanding the dementia diagnosis gap in Norfolk and Suffolk: a survey of general practitionersMargaret Fox
Research Fellow in Dementia Care, School of Rehabilitation Sciences, The Queen s Building, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK
Qual Prim Care 22:101-7. 2014..The Norfolk and Suffolk dementia diagnosis rate (DDR) is below the rate for England in some areas; across the CCGs included in this study, the average DDR was 39.9% with a standard deviation of 5.3...